Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mepolizumab Effectiveness and Allergic Status in Real Life.
Sposato B, Scalese M, Camiciottoli G, Carpagnano GE, Pelaia C, Santus P, Maniscalco M, Corsico A, Grosso A, Baglioni S, Murgia N, Folletti I, Pelaia G, Masieri S, Cavaliere C, Musarra A, Bargagli E, Ricci A, Latorre M, Paggiaro P, Rogliani P. Sposato B, et al. Among authors: scalese m. Int Arch Allergy Immunol. 2021;182(4):311-318. doi: 10.1159/000511147. Epub 2020 Oct 28. Int Arch Allergy Immunol. 2021. PMID: 33113532
Small airway impairment and bronchial hyperresponsiveness in asthma onset.
Sposato B, Scalese M, Migliorini MG, Di Tomassi M, Scala R. Sposato B, et al. Among authors: scalese m. Allergy Asthma Immunol Res. 2014 May;6(3):242-51. doi: 10.4168/aair.2014.6.3.242. Epub 2014 Feb 11. Allergy Asthma Immunol Res. 2014. PMID: 24843800 Free PMC article.
Can the response to Omalizumab be influenced by treatment duration? A real-life study.
Sposato B, Scalese M, Latorre M, Novelli F, Scichilone N, Milanese M, Olivieri C, Perrella A, Paggiaro P; Xolair Italian Study Group. Sposato B, et al. Among authors: scalese m. Pulm Pharmacol Ther. 2017 Jun;44:38-45. doi: 10.1016/j.pupt.2017.03.004. Epub 2017 Mar 14. Pulm Pharmacol Ther. 2017. PMID: 28302544
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes.
Sposato B, Scalese M, Milanese M, Masieri S, Cavaliere C, Latorre M, Scichilone N, Ricci A, Cresti A, Santus P, Olivieri C, Perrella A, Rogliani P, Paggiaro P; Omalizumab Italian Study Group. Sposato B, et al. Among authors: scalese m. J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1643-1646. doi: 10.1016/j.jaip.2019.03.006. Epub 2019 Mar 19. J Allergy Clin Immunol Pract. 2019. PMID: 30898690 No abstract available.
136 results